Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
172 hedge funds and large institutions have $2.46B invested in Medicines Co in 2013 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 81 increasing their positions, 47 reducing their positions, and 25 closing their positions.
357% more call options, than puts
Call options by funds: $16.8M | Put options by funds: $3.66M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
72% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 47
24% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 25
21% more capital invested
Capital invested by funds: $2.04B → $2.46B (+$421M)
2% more funds holding
Funds holding: 168 → 172 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$92.5M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$75.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.6M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$27M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$26.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$51.5M |
| 2 |
BM
Bridger Management
New York
|
-$43.4M |
| 3 |
RIM
RS Investment Management
San Francisco,
California
|
-$27.3M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.7M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$15.8M |
MDCO Hedge Fund Activity: Q3 2013 in Review
172 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q3 2013, worth a combined $2.46B — up 21% from $2.04B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new MDCO positions and 25 closed out — a net gain of 6 holders — while 81 added to existing stakes and 47 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $92.5M. The largest seller was HealthCor Management, exiting entirely with an estimated $51.5M sold.
- 172 institutional investors held Medicines Co (MDCO) as of Q3 2013, up from 168 in Q2 2013.
- Funds reported $2.46B of Medicines Co stock for Q3 2013, up 21% quarter-over-quarter.
- 31 funds opened new Medicines Co positions in Q3 2013 and 25 closed out, a net change of +6 holders.
- The largest Medicines Co buyer in Q3 2013 was Wellington Management Group, an estimated $92.5M added.
- The largest Medicines Co seller in Q3 2013 was HealthCor Management, an estimated $51.5M sold.
Based on aggregated 13F filings for Q3 2013.